Progesterone inhibits gonadotropin-releasing hormone (GnRH) secretion through interneuronal systems located in the mediobasal hypothalamus in ewes. Endogenous opioid peptides are implicated in this inhibition of GnRH secretion. The distributions of endogenous opioid peptides are known to overlap with progesterone receptors (PR) in the arcuate nucleus. We investigated whether PR is expressed by β-endorphin and dynorphin B neurons in the arcuate nucleus and if a subset of double-labeled cells projects to the preoptic area where most GnRH neurons are detected. Injection of a retrograde tracer, Fluorogold, into the rostral preoptic area was performed in ovariectomized ewes pretreated with estrogen and progesterone. Brain sections were processed using double immunocytochemistry. Only brains of ewes with an injection site encompassing at least 80 GnRH neurons were processed for PR and then either β-endorphin or dynorphin B immunocytochemistry. Antigen retrieval is essential for PR detection but causes Fluorogold to fade. Thus, quantitative analysis was performed on photographs taken before and after antigen retrieval. We found that 25–30% of PR-containing neurons, 20% of β-endorphin cells and 22% of dynorphin B neurons in the arcuate nucleus project toward the preoptic area. From the PR/β-endorphin double-labeled cells that represent 25 and 36% of PR and β-endorphin cells, respectively, 35% were labeled with Fluorogold. From the PR/dynorphin B double-labeled cells that account for 39 and 62% of PR and dynorphin B neurons, respectively, 26% contained Fluorogold. These data strongly support the hypothesis that progesterone acts in the arcuate nucleus through β-endorphin and dynorphin B neurons to affect preoptic area GnRH neurons.

1.
Fink G: Oestrogen and progesterone interactions in the control of gonadotrophin and prolactin secretion. J Steroid Biochem 1988;30:169–178.
2.
Goodman RL, Karsch FJ: Pulsatile secretion of luteinizing hormone: Differential suppression by ovarian steroids. Endocrinology 1980;107:1286–1290.
3.
Skinner DC, Bouchard P, Caraty A: The progesterone blockade of the LH surge is overcome by RU486. J Neuroendocrinol 1999;11:637–641.
4.
Skinner DC, Evans NP, Delaleu B, Goodman RL, Bouchard P, Caraty A: The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transduced by the classical progesterone receptor. Proc Natl Acad Sci USA 1998;95:10978–10983.
5.
Skinner DC, Caraty A, Allingham R: Unmasking the progesterone receptor in the preoptic area and the hypothalamus of the ewe: No co-localisation with gonadotropin-releasing neurons. Endocrinology 2001;142:573–579.
6.
Leranth C, MacLusky NJ, Brown TJ, Chen EC, Redmond DE, Naftolin F: Transmitter content and afferent connections of estrogen-sensitive progestin receptor-containing neurons in the primate hypothalamus. Neuroendocrinology 1992;55:667–682.
7.
King JC, Tai DW, Hanna IK, Pfeiffer A, Haas P, Ronsheim PM, Mitchell SC, Turcotte JC, Blaustein JD: A subgroup of LHRH neurons in guinea pigs with progestin receptors is centrally positioned within the total population of LHRH neurons. Neuroendocrinology 1995;61:265–275.
8.
Warembourg M, Leroy D, Peytin J, Martinet L: Estrogen receptor and progesterone receptor-immunoreactive cells are not colocalized with gonadotropin-releasing hormone in the brain of the female mink (Mustela vison). Cell Tiss Res 1998;291:33–41.
9.
Blache D, Fabre-Nys C, Venier G: Inhibition of sexual behaviour and the luteinizing hormone surge by intracerebral progesterone implants in the female sheep. Brain Res 1996;741:117–122.
10.
Skinner DC, Delaleu B, Caraty A: Where in the brain does progesterone inhibit GnRH secretion? Annual Meeting of the Society of Neuroscience, Miami 1999, pp 582–587.
11.
Lehman MN, Robinson JE, Karsch FJ, Silverman AJ: Immunocytochemical localization of luteinizing hormone-releasing hormone pathways in the sheep brain during anestrus and the mid-luteal phase of the estrous cycle. J Comp Neurol 1986;244:19–35.
12.
Cicero TJ, Schainker BA, Meyer ER: Endogenous opioids participate in the regulation of the hypothalamus-pituitary-luteinizing hormone axis and testosterone’s negative feedback control of luteinizing hormone. Endocrinology 1979;104:1286–1291.
13.
Gabriel SM, Simpkins JW, Kalra SP: Modulation of endogenous opioid influence on luteinizing hormone secretion by progesterone and estrogen. Endocrinology 1983;113:1806–1811.
14.
Contijoch AM, Malamed S, Sarkar DK, Advis JP: β-Endorphin regulation of LHRH release at the median eminence level: Immunocytochemical and physiological evidence in hens. Neuroendocrinology 1993;57:365–373.
15.
Orstead KM, Hess DL, Spies HG: Opiatergic inhibition of pulsatile luteinizing hormone release during the menstrual cycle of rhesus macaques. Proc Soc Exp Biol Med 1987;184:312–319.
16.
Goodman RL, Parfitt DB, Evans NP, Dahl GE, Karsch FJ: Endogenous opioid-peptides control the amplitude and shape of gonadotropin-releasing hormone pulses in the ewe. Endocrinology 1995;136:2412–2420.
17.
Horton RJ, Cummins JT, Clarke IJ: Naloxone evokes large-amplitude GnRH pulses in luteal-phase ewes. J Reprod Fertil 1987;81:277–286.
18.
Goodman RL, Coolen LM, Anderson GM, Hardy SL, Valent M, Connors JM, Fitzgerald ME, Lehman MN: Evidence that dynorphin plays a major role in mediating progesterone negative feedback on gonadotropin-releasing hormone neurons in sheep. Endocrinology 2004;145:2959–2967.
19.
Chen WP, Witkin JW, Silverman AJ: Sexual dimorphism in the synaptic input to gonadotropin-releasing hormone neurons. Endocrinology 1990;126:695–702.
20.
Chen WP, Witkin JW, Silverman AJ: β-Endorphin and gonadotropin-releasing hormone synaptic input to gonadotropin-releasing hormone neurosecretory cells in the male rat. J Comp Neurol 1989;286:85–95.
21.
Thind KK, Goldsmith PC: Infundibular gonadotropin-releasing hormone neurons are inhibited by direct opioid and autoregulatory synapses in juvenile monkeys. Neuroendocrinology 1988;47:203–216.
22.
Foradori CD, Goodman RL, Adams VL, Valent M, Lehman ML: Progesterone increases dynorphin A concentrations in cerebrospinal fluid and preprodynorphin messenger ribonucleic acid levels in a subset of dynorphin neurons in the sheep. Endocrinology 2005;146:1835–1842.
23.
Foradori CD, Coolen LM, Fitzgerald ME, Skinner DC, Goodman RL, Lehman MN: Colocalization of progesterone receptors in parvicellular dynorphin neurons of the ovine preoptic area and hypothalamus. Endocrinology 2002;143:4366–4374.
24.
Bethea CL, Widmann AA: Immunohistochemical detection of progestin receptors in hypothalamic β-endorphin and substance P neurons of steroid-treated monkeys. Neuroendocrinology 1996;63:132–141.
25.
Olster DH, Blaustein JD: Immunocytochemical colocalization of progestin receptors and β-endorphin or enkephalin in the hypothalamus of female guinea pigs. J Neurobiol 1990;21:768–780.
26.
Evans NP, Dahl GE, Glover BH, Karsch FJ: Central regulation of pulsatile gonadotropin-releasing hormone (GnRH) secretion by estradiol during the period leading up to the preovulatory GnRH surge in the ewe. Endocrinology 1994;134:1806–1811.
27.
Tillet Y, Batailler M, Thibault J: Neuronal projections to the medial preoptic area of the sheep, with special reference to monoaminergic afferents: Immunohistochemical and retrograde tract tracing studies. J Comp Neurol 1993;330:195–220.
28.
Schmued LC, Fallon JH: Fluoro-Gold: A new fluorescent retrograde axonal tracer with numerous unique properties. Brain Res 1986;377:147–154.
29.
Dado RJ, Burstein R, Cliffer KD, Giesler GJ Jr: Evidence that Fluoro-Gold can be transported avidly through fibers of passage. Brain Res 1990;533:329–333.
30.
Warembourg M, Leroy D: Microwave pretreatment of sections to improve the immunocytochemical detection of progesterone receptors in the guinea pig hypothalamus. J Neurosci Methods 2000;104:27–34.
31.
Herbison AE, Robinson JE, Skinner DC: Distribution of estrogen receptor-immunoreactive cells in the preoptic area of the ewe: Co-localization with glutamic acid decarboxylase but not luteinizing hormone-releasing hormone. Neuroendocrinology 1993;57:751–759.
32.
Lehman MN, Karsch FJ: Do gonadotropin-releasing hormone, tyrosine hydroxylase-, and β-endorphin-immunoreactive neurons contain estrogen receptors? A double-label immunocytochemical study in the Suffolk ewe. Endocrinology 1993;133:887–895.
33.
Skinner DC, Caraty A, Allingham R: Unmasking the progesterone receptor in the preoptic area and hypothalamus of the ewe: No colocalization with gonadotropin-releasing neurons. Endocrinology 2001;142:573–579.
34.
Covenas R, de Leon M, Narvaez JA, Aguirre JA, Tramu G, Gonzalez-Baron S: Anatomical distribution of β-endorphin (1–27) in the cat brainstem: An immunocytochemical study. Anat Embryol (Berl) 1999;199:161–167.
35.
Griffond B, Deray A, Fellmann D, Ciofi P, Croix D, Bugnon C: Colocalization of prolactin- and dynorphin-like substances in a neuronal population of the rat lateral hypothalamus. Neurosci Lett 1993;156:91–95.
36.
Dufourny L, Skinner DC: Progesterone receptor, estrogen receptor α and the type II glucocorticoid receptor are coexpressed in the same neurons of the ovine preoptic area and arcuate nucleus: A triple immunolabeling study. Biol Reprod 2002;67:1605–1612.
37.
Lehman MN, Robinson JE, Karsch FJ, Silverman AJ: Immunocytochemical localization of luteinizing hormone-releasing hormone pathways in the sheep brain during anestrus and the mid-luteal phase of the estrous cycle. J Comp Neurol 1986;244:19–35.
38.
Caldani M, Batailler M, Thiery JC, Dubois MP: LHRH-immunoreactive structures in the sheep brain. Histochemistry 1988;89:129–139.
39.
Goubillon ML, Delaleu B, Tillet Y, Caraty A, Herbison AE: Localization of estrogen-receptive neurons projecting to the GnRH neuron-containing rostral preoptic area of the ewe. Neuroendocrinology 1999;70:228–236.
40.
Scott CJ, Clarke IJ, Tilbrook AJ: Neuronal inputs from the hypothalamus and brain stem to the medial preoptic area of the ram: Neurochemical correlates and comparison to the ewe. Biol Reprod 2003;68:1119–1133.
41.
Whisnant CS, Curto K, Goodman RL: Immunocytochemical localization of β-endorphin and gonadal steroid regulation of proopiomelanocortin messenger ribonucleic acid in the ewe. Neuroendocrinology 1992;56:812–821.
42.
Foradori CD, Coolen LM, Fitzgerald ME, Skinner DC, Goodman RL, Lehman MN: Colocalization of progesterone receptors in parvicellular dynorphin neurons of the ovine preoptic area and hypothalamus. Endocrinology 2002;143:4366–4374.
43.
Blache D, Fabre-Nys C, Venier G: Inhibition of sexual behaviour and the luteinizing hormone surge by intracerebral progesterone implants in the female sheep. Brain Res 1996;741:117–122.
44.
Skinner DC, Delaleu B, Caraty A: Where in the brain does progesterone inhibit GnRH secretion? Abstracts of 29th Meeting of the Society for Neuroscience, Miami 1999, vol 25, pp 582–587.
45.
Kruse MN, Erdman SL, Puri G, de Groat WC: Differences in Fluorogold and wheat germ agglutinin-horseradish peroxidase labelling of bladder afferent neurons. Brain Res 1993;613:352–356.
46.
Tillet Y, Batailler M, Thiery JC, Thibault J: Neuronal projections to the lateral retrochiasmatic area of sheep with special reference to catecholaminergic afferents: Immunohistochemical and retrograde tract-tracing studies. J Chem Neuroanat 2000;19:47–67.
47.
Simonian SX, Spratt DP, Herbison AE: Identification and characterization of estrogen receptor α-containing neurons projecting to the vicinity of the gonadotropin-releasing hormone perikarya in the rostral preoptic area of the rat. J Comp Neurol 1999;411:346–358.
48.
Olster DH, Blaustein JD: Immunocytochemical colocalization of progestin receptors and β-endorphin or enkephalin in the hypothalamus of female guinea pigs. J Neurobiol 1990;21:768–780.
49.
Bethea CL, Widmann AA: Immunohistochemical detection of progestin receptors in hypothalamic β-endorphin and substance P neurons of steroid treated monkeys. Neuroendocrinology 1996;63:132–141.
50.
Fox SR, Harlan RE, Shivers BD, Pfaff DW: Chemical characterization of neuroendocrine targets for progesterone in the female rat brain and pituitary. Neuroendocrinology 1990;51:276–283.
51.
Blaustein JD, Turcotte JC: Estradiol-induced progestin receptor immunoreactivity is found only in estrogen receptor-immunoreactive cells in guinea pig brain. Neuroendocrinology 1989;49:454–461.
52.
Warembourg M, Jolivet A, Milgrom E: Immunohistochemical evidence of the presence of estrogen and progesterone receptors in the same neurons of the guinea pig hypothalamus and preoptic area. Brain Res 1989;480:1–15.
53.
Axelson JF, Van Leeuwen FW: Differential localization of estrogen receptors in various vasopressin synthesizing nuclei of the rat brain. J Neuroendocrinol 1990;2:209–216.
54.
Warembourg M, Jolivet A: Immunocytochemical localization of progesterone receptors in galanin neurons in the guinea pig hypothalamus. J Neuroendocrinol 1993;5:487–491.
55.
Weber E, Barchas JD: Immunohistochemical distribution of dynorphin B in rat brain: Relation to dynorphin A and α-neo-endorphin systems. Proc Natl Acad Sci USA 1983;80:1125–1129.
56.
Kakidani H, Furutani Y, Takahashi H, Noda M, Morimoto Y, Hirose T, Asai M, Inayama S, Nakanishi S, Numa S: Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor. Nature 1982;298:245–249.
57.
Fullerton MJ, Smith AI, Funder JW: Immunoreactive dynorphin is regulated by estrogen in the rat anterior pituitary. Neuroendocrinology 1988;47:1–6.
58.
Simerly RB, Young BJ, Carr AM: Co-expression of steroid hormone receptors in opioid peptide-containing neurons correlates with patterns of gene expression during the estrous cycle. Brain Res Mol Brain Res 1996;40:275–284.
59.
McGinty JF, Bloom FE: Double immunostaining reveals distinctions among opioid peptidergic neurons in the medial basal hypothalamus. Brain Res 1983;278:145–153.
60.
Thind KK, Goldsmith PC: Infundibular gonadotropin-releasing hormone neurons are inhibited by direct opioid and autoregulatory synapses in juvenile monkeys. Neuroendocrinology 1988;47:203–216.
61.
Chen WP, Witkin JW, Silverman AJ: β-Endorphin and gonadotropin-releasing hormone synaptic input to gonadotropin-releasing hormone neurosecretory cells in the male rat. J Comp Neurol 1989;286:85–95.
62.
Mitchell V, Prevot V, Jennes L, Aubert JP, Croix D, Beauvillain JC: Presence of μ and κ opioid receptor mRNAs in galanin but not in GnRH neurons in the female rat. Neuroreport 1997;8:3167–3172.
63.
Sannella MI, Petersen SL: Dual label in situ hybridization studies provide evidence that luteinizing hormone-releasing hormone neurons do not synthesize messenger ribonucleic acid for μ, κ, or δ opiate receptors. Endocrinology 1997;138:1667–1672.
64.
Ottinger MA, Thompson N, Gorski R, Micevych P: Discrete population of GnRH neurons express δ-opioid receptor: A marker for aging. Society for Neuroscience Meeting, New Orleans 2000, pp 658–665.
65.
Jansen HT, Cutter C, Hardy S, Lehman MN, Goodman RL: Seasonal plasticity within the gonadotropin-releasing hormone system of the ewe: Changes in identified GnRH inputs and glial association. Endocrinology 2003;144:3663–3676.
66.
Ullian EM, Sapperstein SK, Christopherson KS, Barres BA: Control of synapse number by glia. Science 2001;291:657–661.
67.
Pompolo S, Pereira A, Kaneko T, Clarke IJ: Seasonal changes in the inputs to gonadotropin-releasing hormone neurones in the ewe brain: An assessment by conventional fluorescence and confocal microscopy. J Neuroendocrinol 2003;15:538–545.
68.
Estrada KM, Pompolo S, Morris MJ, Tilbrook AJ, Clarke IJ: Neuropeptide Y (NPY) delays the oestrogen-induced luteinizing hormone (LH) surge in the ovariectomized ewe: Further evidence that NPY has a predominant negative effect on LH secretion in the ewe. J Neuroendocrinol 2003;15:1011–1020.
69.
Mills RH, Sohn RK, Micevych PE: Estrogen-induced μ-opioid receptor internalization in the medial preoptic nucleus is mediated via neuropeptide Y-Y1 receptor activation in the arcuate nucleus of female rats. J Neurosci 2004;24:947–955.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.